Back to Results
First PageMeta Content
Monoclonal antibodies / Pharmacology / Psoriasis / Centocor / Autoimmune diseases / Ustekinumab / Psoriatic nails / Infliximab / Etanercept / Medicine / Immunosuppressants / Health


Ixekizumab for moderate to severe chronic plaque psoriasis
Add to Reading List

Open Document

File Size: 161,78 KB

Share Result on Facebook

City

Manchester / London / Edinburgh / /

Company

AEs / Eli Lilly and Company / The New England Journal / Lilly / NIHR Horizon Scanning Centre TARGET GROUP / ADVANTAGES If / Patient.co.uk / /

Country

United States / Canada / United Kingdom / Denmark / Wales / /

Currency

GBP / /

/

Event

FDA Phase / /

Facility

National Institute / Hospital Anxiety / University of Birmingham Email / University of Birmingham / /

IndustryTerm

health technology / nihrhsc@contacts.bham.ac.uk Web / NICE technology appraisal / treatment of inflammatory disease / therapies for psoriasis / treatment of psoriasis / literature search / technology appraisal / /

MarketIndex

Psoriasis Area Severity / /

MedicalCondition

severe psoriasis / nail psoriasis / headache / palmoplantar psoriasis / rheumatoid arthritis / Plaque psoriasis / heart disease / severe plaque psoriasis / severe chronic plaque psoriasis / psoriasis / severe disease / pruritus / infections / psoriatic arthritis / inflammatory skin condition / refractory psoriasis / disease / inflammatory skin conditions / nasopharyngitis / chronic / upper respiratory infection / erythema / metabolic syndrome / pain / scalp psoriasis / PATIENT GROUP BACKGROUND Psoriasis / inflammation / depression / inflammatory / /

MedicalTreatment

phototherapy / biological therapy / biological therapies / /

Movie

Quality of life / /

MusicGroup

UVB / /

Organization

Dermatologists and Primary Care Dermatology Society / British Association of Dermatologists / University of Birmingham Email / Office for National Statistics / Horizon Scanning Centre / NIHR Horizon Scanning Centre / University of Birmingham / National Institute for Health Research / Primary Care Dermatology Society / American Academy / European Union / Department of Health / NHS / Institute for Health / /

Person

Infliximab (Remicade) Ustekinumab / Drug Adalimumab (Humira) / Etanercept (Enbrel) Infliximab / /

Position

physician / candidate for phototherapy and/or systemic therapy / consultant / author / Governor / candidate for systemic therapy / /

Product

calcitriol / Humira / Vitamin D / Remicade / Enbrel / SC injection / betamethasone dipropionate / I1F-MC / /

ProvinceOrState

South Carolina / /

PublishedMedium

British Journal of Dermatology / PLOS ONE / Archives of Dermatology / The New England Journal of Medicine / /

Region

New England / /

Technology

health technology / drug development / /

URL

www.hscic.gov.uk / http /

SocialTag